Avadomide hydrochloride is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor.

Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg12O12 and Zn12O12 nanoclusters: an in silico strategy for COVID-19 treatment.

Avadomide hydrochloride is under clinical development by Bristol-Myers Squibb and currently in Phase I for Glioblastoma Multiforme (GBM).

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.